2-(3-((4-Methoxybenzyl)oxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 250mg

Methyl 2-(1-benzylpiperidin-4-ylidene)acetate, 95.0%, 1g

(2S,3S)-2,3-Bis((2-methylbenzoyl)oxy)succinic acid, 95.0%, 250mg

2-Bromo-5-trifluoromethylthiophene, 85.0%, 25g

1-(2-Chloro-4-nitrophenyl)-piperazine, 98.0%, 5g

2-(Piperidin-4-ylidene)acetic acid hydrochloride, 95.0%, 250mg

7-Chlorothiazolo[5,4-d]pyrimidine, 95.0%, 25g

Boîte carrée ROTILABO®, 2500 ml, 1 Pièce

Methyl-(2-phenoxy-ethyl)-amine, 95.0%, 5g

5-Amino-1,3-dimethyl-1,3-dihydro-benzoimidazol-2-one, 95.0%, 25g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-methyl-1H-indol-3-yl)propanoic acid, 95%, 250mg

L-cystine, 25 g

4-((4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)sulfonyl)morpholine, 98%, 25g